zonisamide

Generic: zonisamide

Labeler: preferred pharmaceuticals inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name zonisamide
Generic Name zonisamide
Labeler preferred pharmaceuticals inc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

zonisamide 100 mg/1

Manufacturer
Preferred Pharmaceuticals Inc

Identifiers & Regulatory

Product NDC 68788-4004
Product ID 68788-4004_061fdccc-d08e-4e42-8a32-54afb6c89701
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077625
Listing Expiration 2026-12-31
Marketing Start 2022-07-04

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa] p-glycoprotein inhibitors [moa]
Chemical Structure
sulfonamides [cs]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687884004
Hyphenated Format 68788-4004

Supplemental Identifiers

RxCUI
314285
UNII
459384H98V
NUI
N0000175753 N0000008486 M0020790 N0000000235 N0000185503

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zonisamide (source: ndc)
Generic Name zonisamide (source: ndc)
Application Number ANDA077625 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (68788-4004-6)
source: ndc

Packages (1)

Ingredients (1)

zonisamide (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "061fdccc-d08e-4e42-8a32-54afb6c89701", "openfda": {"nui": ["N0000175753", "N0000008486", "M0020790", "N0000000235", "N0000185503"], "unii": ["459384H98V"], "rxcui": ["314285"], "spl_set_id": ["061fdccc-d08e-4e42-8a32-54afb6c89701"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc"]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (68788-4004-6)", "package_ndc": "68788-4004-6", "marketing_start_date": "20250801"}], "brand_name": "Zonisamide", "product_id": "68788-4004_061fdccc-d08e-4e42-8a32-54afb6c89701", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "P-Glycoprotein Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "68788-4004", "generic_name": "Zonisamide", "labeler_name": "Preferred Pharmaceuticals Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zonisamide", "active_ingredients": [{"name": "ZONISAMIDE", "strength": "100 mg/1"}], "application_number": "ANDA077625", "marketing_category": "ANDA", "marketing_start_date": "20220704", "listing_expiration_date": "20261231"}